These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7772402

  • 1. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
    Akiyama Y, Yamasaki T, Fukuda M, Moritake K.
    No To Shinkei; 1995 Apr; 47(4):349-55. PubMed ID: 7772402
    [Abstract] [Full Text] [Related]

  • 2. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
    Ohyama K.
    Nihon Geka Hokan; 1993 Mar 01; 62(2):92-115. PubMed ID: 8239865
    [Abstract] [Full Text] [Related]

  • 3. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
    Ohyama K, Kikuchi H, Oda Y, Moritake K, Yamasaki T.
    No To Shinkei; 1993 Jun 01; 45(6):525-30. PubMed ID: 8363848
    [Abstract] [Full Text] [Related]

  • 4. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW, Leu NR, Shannon BJ, Fast DJ.
    J Immunol; 1991 Sep 15; 147(6):1816-22. PubMed ID: 1909732
    [Abstract] [Full Text] [Related]

  • 5. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H, Stewart CA, Fast DJ, Leu RW.
    J Immunol; 1992 Sep 15; 149(6):2137-46. PubMed ID: 1517576
    [Abstract] [Full Text] [Related]

  • 6. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL, Perera PY, Salkowski CA, Vogel SN.
    J Immunol; 1994 Jan 15; 152(2):825-31. PubMed ID: 7506736
    [Abstract] [Full Text] [Related]

  • 7. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
    Jun CD, Yoon HJ, Kim HM, Chung HT.
    Biochem Biophys Res Commun; 1995 Jan 26; 206(3):969-74. PubMed ID: 7832812
    [Abstract] [Full Text] [Related]

  • 8. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages.
    Kirikae T, Ojima I, Ma Z, Kirikae F, Hirai Y, Nakano M.
    Biochem Biophys Res Commun; 1998 Apr 28; 245(3):698-704. PubMed ID: 9588177
    [Abstract] [Full Text] [Related]

  • 9. An improved experimental model for the study of in vitro release of nitric oxide by murine peritoneal macrophages.
    Marcinkiewicz J, Pater M, Grabowska A.
    Arch Immunol Ther Exp (Warsz); 1994 Apr 28; 42(2):95-9. PubMed ID: 7503653
    [Abstract] [Full Text] [Related]

  • 10. In vivo cisplatin-exposed macrophages increase immunostimulant-induced nitric oxide synthesis for tumor cell killing.
    Son K, Kim YM.
    Cancer Res; 1995 Dec 01; 55(23):5524-7. PubMed ID: 7585626
    [Abstract] [Full Text] [Related]

  • 11. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.
    Hatzigeorgiou DE, He S, Sobel J, Grabstein KH, Hafner A, Ho JL.
    J Immunol; 1993 Oct 01; 151(7):3682-92. PubMed ID: 8397259
    [Abstract] [Full Text] [Related]

  • 12. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
    Calderon CL, Torroella-Kouri M, Dinapoli MR, Lopez DM.
    Int J Oncol; 2008 Mar 01; 32(3):713-21. PubMed ID: 18292949
    [Abstract] [Full Text] [Related]

  • 13. Structural requirements of taxoids for nitric oxide and tumor necrosis factor production by murine macrophages.
    Kirikae T, Ojima I, Kirikae F, Ma Z, Kuduk SD, Slater JC, Takeuchi CS, Bounaud PY, Nakano M.
    Biochem Biophys Res Commun; 1996 Oct 03; 227(1):227-35. PubMed ID: 8858130
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma.
    Kichian K, Nestel FP, Kim D, Ponka P, Lapp WS.
    J Immunol; 1996 Oct 01; 157(7):2851-6. PubMed ID: 8816389
    [Abstract] [Full Text] [Related]

  • 16. Effect of L-arginine on the retention of macrophage tumoricidal activity.
    Takema M, Inaba K, Uno K, Kakihara K, Tawara K, Muramatsu S.
    J Immunol; 1991 Mar 15; 146(6):1928-33. PubMed ID: 2005387
    [Abstract] [Full Text] [Related]

  • 17. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG, Burger CJ, Elgert KD.
    Oncol Res; 1994 Mar 15; 6(4-5):219-28. PubMed ID: 7841545
    [Abstract] [Full Text] [Related]

  • 18. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene.
    Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ.
    J Immunol; 1998 Nov 01; 161(9):4803-10. PubMed ID: 9794412
    [Abstract] [Full Text] [Related]

  • 19. Cellular models of macrophage tumoricidal effector mechanisms in vitro. Characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro.
    Klostergaard J, Leroux ME, Hung MC.
    J Immunol; 1991 Oct 15; 147(8):2802-8. PubMed ID: 1918993
    [Abstract] [Full Text] [Related]

  • 20. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
    Taylor LS, Cox GW, Melillo G, Bosco MC, Espinoza-Delgado I.
    Cancer Res; 1997 Jun 15; 57(12):2468-73. PubMed ID: 9192827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.